^
Association details:
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Title:

RNA Expression of DNA Damage Response Genes in Muscle-Invasive Bladder Cancer: Influence on Outcome and Response to Adjuvant Cisplatin-Based Chemotherapy

Published date:
04/18/2021
Excerpt:
Subgroup analyses were performed in patients who received adjuvant cisplatin-based chemotherapy (ACBC)....Low expression of RAD52 was associated with low DFS in both the Mannheim and the TCGA cohorts (Mannheim: p = 0.039; TCGA: p = 0.017).
DOI:
10.3390/ijms22084188